Screener
Aurinia Pharmaceuticals AUPH Cash Flow Statement
| Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | ||
|---|---|---|---|---|---|---|
| $31.7M+0.5% | $37.41M+73.9% | $34.36M+47.2% | $210.79M+14,651% | $31.55M+120% | ||
| $4.84M-0.5% | $4.83M-0.6% | $4.82M-0.8% | $4.86M0.0% | $4.87M-0.6% | ||
| $6.12M+3.5% | $2.84M-47.8% | -$866K+74.6% | $6.73M-24.8% | $5.92M-28.9% | ||
| $46.37M+4.3% | $52.57M+18.8% | $32.56M+2,405% | $45.67M+51.7% | $44.45M+161% | ||
| -$175.73M— | $81.45M— | -$18.08M-158% | -$36.76M-194% | —— | ||
| —— | $38.72M-9.0% | $36.17M-22.9% | $0-100% | $8.67M— | ||
| -$4.32M+58.8% | —— | -$53.69M-8.8% | -$1.89M+91.8% | -$10.49M-285% | ||
| -$133.69M— | $138.82M+1,134% | -$39.21M-131% | —— | —— |
FAQ
- How much cash does Aurinia Pharmaceuticals generate?
- Aurinia Pharmaceuticals (AUPH) generated $177.2M in operating cash flow over the trailing twelve months.
- Where does Aurinia Pharmaceuticals's cash flow data come from?
- Every line is extracted from Aurinia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
